CIP
Convergence Investment Partners Portfolio holdings
AUM
$394M
1-Year Return
46.21%
This Quarter Return
+4.25%
1 Year Return
+46.21%
3 Year Return
+151.23%
5 Year Return
+294.48%
10 Year Return
+725%
AUM
$720M
AUM Growth
-$26.9M
(-3.6%)
Cap. Flow
-$41.2M
Cap. Flow
% of AUM
-5.72%
Top 10 Holdings %
Top 10 Hldgs %
11.03%
Holding
470
New
120
Increased
125
Reduced
110
Closed
112
Top Buys
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$5.02M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$4.34M |
| 3 |
Merck
MRK
|
$4.14M |
| 4 |
Citigroup
C
|
$3.88M |
| 5 |
Amgen
AMGN
|
$3.83M |
Top Sells
| 1 |
Oracle
ORCL
|
$7.93M |
| 2 |
Morgan Stanley
MS
|
$6.89M |
| 3 |
Phillips 66
PSX
|
$5.71M |
| 4 |
JPMorgan Chase
JPM
|
$4.75M |
| 5 |
Valero Energy
VLO
|
$4.65M |
Sector Composition
| 1 | Technology | 14.77% |
| 2 | Financials | 14.29% |
| 3 | Healthcare | 12.04% |
| 4 | Industrials | 11.99% |
| 5 | Consumer Discretionary | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Griffon
GFF
$3.79B
| $309K | 0.04% |
+17,739
| New | +$309K |
|
|
ABB
327
DELISTED
ABB Ltd.
ABB
| $304K | 0.04% |
14,381
-1,877
| -12% | -$39.7K |
|
328
Brookfield
BN
$99.5B
| $294K | 0.04% |
15,633
-11,009
| -41% | -$207K |
|
329
AB InBev
BUD
$118B
| $273K | 0.04% |
2,242
-365
| -14% | -$44.4K |
|
330
HP
HPQ
$27.4B
| $271K | 0.04% |
19,166
-327,363
| -94% | -$4.63M |
|
331
Coca-Cola
KO
$292B
| $271K | 0.04% |
6,674
-84
| -1% | -$3.41K |
|
332
Goldman Sachs
GS
$223B
| $264K | 0.04% |
1,403
-3
| -0.2% | -$565 |
|
333
Amazon
AMZN
$2.48T
| $261K | 0.04% |
+14,020
| New | +$261K |
|
334
Sanofi
SNY
$113B
| $261K | 0.04% |
5,275
+660
| +14% | +$32.7K |
|
335
McKesson
MCK
$85.5B
| $241K | 0.03% |
1,067
| – | – |
|
336
Costco
COST
$427B
| $236K | 0.03% |
1,560
-11,501
| -88% | -$1.74M |
|
337
Medtronic
MDT
$119B
| $234K | 0.03% |
+3,002
| New | +$234K |
|
338
GSK
GSK
$81.5B
| $233K | 0.03% |
4,046
+67
| +2% | +$3.86K |
|
339
Novo Nordisk
NVO
$245B
| $228K | 0.03% |
8,540
-1,208
| -12% | -$32.3K |
|
|
CHL
340
DELISTED
China Mobile Limited
CHL
| $226K | 0.03% |
3,468
-517
| -13% | -$33.7K |
|
|
ESRX
341
DELISTED
Express Scripts Holding Company
ESRX
| $218K | 0.03% |
2,514
-1
| -0% | -$87 |
|
342
UBS Group
UBS
$128B
| $215K | 0.03% |
+11,460
| New | +$215K |
|
343
Elevance Health
ELV
$70.6B
| $214K | 0.03% |
+1,383
| New | +$214K |
|
344
HSBC
HSBC
$227B
| $213K | 0.03% |
5,672
-3,596
| -39% | -$135K |
|
345
US Bancorp
USB
$75.9B
| $204K | 0.03% |
4,662
-3
| -0.1% | -$131 |
|
346
Mitsubishi UFJ Financial
MUFG
$174B
| $176K | 0.02% |
28,253
-2,613
| -8% | -$16.3K |
|
347
Banco Santander
SAN
$141B
| $161K | 0.02% |
22,803
-5,481
| -19% | -$38.7K |
|
348
Lloyds Banking Group
LYG
$64.5B
| $148K | 0.02% |
31,653
-2,930
| -8% | -$13.7K |
|
349
Sumitomo Mitsui Financial
SMFG
$105B
| $110K | 0.02% |
14,270
+751
| +6% | +$5.79K |
|
350
Banco Bilbao Vizcaya Argentaria
BBVA
$105B
| $108K | 0.02% |
+11,362
| New | +$108K |
|